Kenneth Pienta
Kenneth Pienta
Professor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins University
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
40722005
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ...
Nature 419 (6907), 624-629, 2002
27072002
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
20802015
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
JS De Bono, HI Scher, RB Montgomery, C Parker, MC Miller, H Tissing, ...
Clinical cancer research 14 (19), 6302-6309, 2008
20212008
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ...
Nature 412 (6849), 822-826, 2001
19552001
The mutational landscape of lethal castration-resistant prostate cancer
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...
Nature 487 (7406), 239-243, 2012
19002012
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone
RS Taichman, C Cooper, ET Keller, KJ Pienta, NS Taichman, ...
Cancer research 62 (6), 1832-1837, 2002
11722002
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
9462007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
8772007
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ...
Nature genetics 45 (12), 1446, 2013
8422013
α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ...
Jama 287 (13), 1662-1670, 2002
8062002
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
7702005
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ...
Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008
7032008
Autoantibody signatures in prostate cancer
X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ...
New England Journal of Medicine 353 (12), 1224-1235, 2005
7032005
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ...
Cancer and Metastasis Reviews 29 (4), 709-722, 2010
7012010
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program
RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ...
Cancer research 64 (24), 9209-9216, 2004
6502004
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Q Wang, W Li, XS Liu, JS Carroll, OA Jšnne, EK Keeton, AM Chinnaiyan, ...
Molecular cell 27 (3), 380-392, 2007
6382007
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
P Esper, FEI Mo, G Chodak, M Sinner, D Cella, KJ Pienta
Urology 50 (6), 920-928, 1997
6041997
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Y Shiozawa, EA Pedersen, AM Havens, Y Jung, A Mishra, J Joseph, ...
The Journal of clinical investigation 121 (4), 1298-1312, 2011
5992011
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
HI Scher, X Jia, JS de Bono, M Fleisher, KJ Pienta, D Raghavan, G Heller
The lancet oncology 10 (3), 233-239, 2009
5972009
The system can't perform the operation now. Try again later.
Articles 1–20